Global Rubella Diagnostic Testing Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Rubella Diagnostic Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Flow Cytometry
  • 1.2.3 Latex Slide Agglutination Test
  • 1.2.4 Monoclonal Antibodies
  • 1.2.5 Immunoassays
  • 1.2.6 Serological Testing
  • 1.2.7 Clinical Evaluation
• 1.3 Market by Application
  • 1.3.1 Global Rubella Diagnostic Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Hospitals
  • 1.3.3 Commercial
  • 1.3.4 Physician Offices
  • 1.3.5 Public Health Labs
  • 1.3.6 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Rubella Diagnostic Testing Market Perspective (2017-2028)
• 2.2 Rubella Diagnostic Testing Growth Trends by Region
  • 2.2.1 Rubella Diagnostic Testing Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Rubella Diagnostic Testing Historic Market Size by Region (2017-2022)
  • 2.2.3 Rubella Diagnostic Testing Forecasted Market Size by Region (2023-2028)
• 2.3 Rubella Diagnostic Testing Market Dynamics
  • 2.3.1 Rubella Diagnostic Testing Industry Trends
  • 2.3.2 Rubella Diagnostic Testing Market Drivers
  • 2.3.3 Rubella Diagnostic Testing Market Challenges
  • 2.3.4 Rubella Diagnostic Testing Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Rubella Diagnostic Testing Players by Revenue
  • 3.1.1 Global Top Rubella Diagnostic Testing Players by Revenue (2017-2022)
  • 3.1.2 Global Rubella Diagnostic Testing Revenue Market Share by Players (2017-2022)
• 3.2 Global Rubella Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Rubella Diagnostic Testing Revenue
• 3.4 Global Rubella Diagnostic Testing Market Concentration Ratio
  • 3.4.1 Global Rubella Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Rubella Diagnostic Testing Revenue in 2021
• 3.5 Rubella Diagnostic Testing Key Players Head office and Area Served
• 3.6 Key Players Rubella Diagnostic Testing Product Solution and Service
• 3.7 Date of Enter into Rubella Diagnostic Testing Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Rubella Diagnostic Testing Breakdown Data by Type

• 4.1 Global Rubella Diagnostic Testing Historic Market Size by Type (2017-2022)
• 4.2 Global Rubella Diagnostic Testing Forecasted Market Size by Type (2023-2028)

5 Rubella Diagnostic Testing Breakdown Data by Application

• 5.1 Global Rubella Diagnostic Testing Historic Market Size by Application (2017-2022)
• 5.2 Global Rubella Diagnostic Testing Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Rubella Diagnostic Testing Market Size (2017-2028)
• 6.2 North America Rubella Diagnostic Testing Market Size by Type
  • 6.2.1 North America Rubella Diagnostic Testing Market Size by Type (2017-2022)
  • 6.2.2 North America Rubella Diagnostic Testing Market Size by Type (2023-2028)
  • 6.2.3 North America Rubella Diagnostic Testing Market Share by Type (2017-2028)
• 6.3 North America Rubella Diagnostic Testing Market Size by Application
  • 6.3.1 North America Rubella Diagnostic Testing Market Size by Application (2017-2022)
  • 6.3.2 North America Rubella Diagnostic Testing Market Size by Application (2023-2028)
  • 6.3.3 North America Rubella Diagnostic Testing Market Share by Application (2017-2028)
• 6.4 North America Rubella Diagnostic Testing Market Size by Country
  • 6.4.1 North America Rubella Diagnostic Testing Market Size by Country (2017-2022)
  • 6.4.2 North America Rubella Diagnostic Testing Market Size by Country (2023-2028)
  • 6.4.3 U.S.
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Rubella Diagnostic Testing Market Size (2017-2028)
• 7.2 Europe Rubella Diagnostic Testing Market Size by Type
  • 7.2.1 Europe Rubella Diagnostic Testing Market Size by Type (2017-2022)
  • 7.2.2 Europe Rubella Diagnostic Testing Market Size by Type (2023-2028)
  • 7.2.3 Europe Rubella Diagnostic Testing Market Share by Type (2017-2028)
• 7.3 Europe Rubella Diagnostic Testing Market Size by Application
  • 7.3.1 Europe Rubella Diagnostic Testing Market Size by Application (2017-2022)
  • 7.3.2 Europe Rubella Diagnostic Testing Market Size by Application (2023-2028)
  • 7.3.3 Europe Rubella Diagnostic Testing Market Share by Application (2017-2028)
• 7.4 Europe Rubella Diagnostic Testing Market Size by Country
  • 7.4.1 Europe Rubella Diagnostic Testing Market Size by Country (2017-2022)
  • 7.4.2 Europe Rubella Diagnostic Testing Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Rubella Diagnostic Testing Market Size (2017-2028)
• 8.2 Asia-Pacific Rubella Diagnostic Testing Market Size by Type
  • 8.2.1 Asia-Pacific Rubella Diagnostic Testing Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Rubella Diagnostic Testing Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Rubella Diagnostic Testing Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Rubella Diagnostic Testing Market Size by Application
  • 8.3.1 Asia-Pacific Rubella Diagnostic Testing Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Rubella Diagnostic Testing Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Rubella Diagnostic Testing Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Rubella Diagnostic Testing Market Size by Region
  • 8.4.1 Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Rubella Diagnostic Testing Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Rubella Diagnostic Testing Market Size (2017-2028)
• 9.2 Latin America Rubella Diagnostic Testing Market Size by Type
  • 9.2.1 Latin America Rubella Diagnostic Testing Market Size by Type (2017-2022)
  • 9.2.2 Latin America Rubella Diagnostic Testing Market Size by Type (2023-2028)
  • 9.2.3 Latin America Rubella Diagnostic Testing Market Share by Type (2017-2028)
• 9.3 Latin America Rubella Diagnostic Testing Market Size by Application
  • 9.3.1 Latin America Rubella Diagnostic Testing Market Size by Application (2017-2022)
  • 9.3.2 Latin America Rubella Diagnostic Testing Market Size by Application (2023-2028)
  • 9.3.3 Latin America Rubella Diagnostic Testing Market Share by Application (2017-2028)
• 9.4 Latin America Rubella Diagnostic Testing Market Size by Country
  • 9.4.1 Latin America Rubella Diagnostic Testing Market Size by Country (2017-2022)
  • 9.4.2 Latin America Rubella Diagnostic Testing Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Rubella Diagnostic Testing Market Size (2017-2028)
• 10.2 Middle East & Africa Rubella Diagnostic Testing Market Size by Type
  • 10.2.1 Middle East & Africa Rubella Diagnostic Testing Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Rubella Diagnostic Testing Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Rubella Diagnostic Testing Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Rubella Diagnostic Testing Market Size by Application
  • 10.3.1 Middle East & Africa Rubella Diagnostic Testing Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Rubella Diagnostic Testing Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Rubella Diagnostic Testing Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Rubella Diagnostic Testing Market Size by Country
  • 10.4.1 Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Rubella Diagnostic Testing Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Abbott Laboratories
  • 11.1.1 Abbott Laboratories Company Details
  • 11.1.2 Abbott Laboratories Business Overview
  • 11.1.3 Abbott Laboratories Rubella Diagnostic Testing Introduction
  • 11.1.4 Abbott Laboratories Revenue in Rubella Diagnostic Testing Business (2017-2022)
  • 11.1.5 Abbott Laboratories Recent Developments
• 11.2 Beckman Coulter
  • 11.2.1 Beckman Coulter Company Details
  • 11.2.2 Beckman Coulter Business Overview
  • 11.2.3 Beckman Coulter Rubella Diagnostic Testing Introduction
  • 11.2.4 Beckman Coulter Revenue in Rubella Diagnostic Testing Business (2017-2022)
  • 11.2.5 Beckman Coulter Recent Developments
• 11.3 Bio Rad Laboratories
  • 11.3.1 Bio Rad Laboratories Company Details
  • 11.3.2 Bio Rad Laboratories Business Overview
  • 11.3.3 Bio Rad Laboratories Rubella Diagnostic Testing Introduction
  • 11.3.4 Bio Rad Laboratories Revenue in Rubella Diagnostic Testing Business (2017-2022)
  • 11.3.5 Bio Rad Laboratories Recent Developments
• 11.4 Biogate Laboratories
  • 11.4.1 Biogate Laboratories Company Details
  • 11.4.2 Biogate Laboratories Business Overview
  • 11.4.3 Biogate Laboratories Rubella Diagnostic Testing Introduction
  • 11.4.4 Biogate Laboratories Revenue in Rubella Diagnostic Testing Business (2017-2022)
  • 11.4.5 Biogate Laboratories Recent Developments
• 11.5 BioMerieux SA
  • 11.5.1 BioMerieux SA Company Details
  • 11.5.2 BioMerieux SA Business Overview
  • 11.5.3 BioMerieux SA Rubella Diagnostic Testing Introduction
  • 11.5.4 BioMerieux SA Revenue in Rubella Diagnostic Testing Business (2017-2022)
  • 11.5.5 BioMerieux SA Recent Developments
• 11.6 Cigna
  • 11.6.1 Cigna Company Details
  • 11.6.2 Cigna Business Overview
  • 11.6.3 Cigna Rubella Diagnostic Testing Introduction
  • 11.6.4 Cigna Revenue in Rubella Diagnostic Testing Business (2017-2022)
  • 11.6.5 Cigna Recent Developments
• 11.7 Diagnostic Laboratory of Oklahoma
  • 11.7.1 Diagnostic Laboratory of Oklahoma Company Details
  • 11.7.2 Diagnostic Laboratory of Oklahoma Business Overview
  • 11.7.3 Diagnostic Laboratory of Oklahoma Rubella Diagnostic Testing Introduction
  • 11.7.4 Diagnostic Laboratory of Oklahoma Revenue in Rubella Diagnostic Testing Business (2017-2022)
  • 11.7.5 Diagnostic Laboratory of Oklahoma Recent Developments
• 11.8 GlaxoSmithKline
  • 11.8.1 GlaxoSmithKline Company Details
  • 11.8.2 GlaxoSmithKline Business Overview
  • 11.8.3 GlaxoSmithKline Rubella Diagnostic Testing Introduction
  • 11.8.4 GlaxoSmithKline Revenue in Rubella Diagnostic Testing Business (2017-2022)
  • 11.8.5 GlaxoSmithKline Recent Developments
• 11.9 HealthLink BC
  • 11.9.1 HealthLink BC Company Details
  • 11.9.2 HealthLink BC Business Overview
  • 11.9.3 HealthLink BC Rubella Diagnostic Testing Introduction
  • 11.9.4 HealthLink BC Revenue in Rubella Diagnostic Testing Business (2017-2022)
  • 11.9.5 HealthLink BC Recent Developments
• 11.10 Mayo Clinic
  • 11.10.1 Mayo Clinic Company Details
  • 11.10.2 Mayo Clinic Business Overview
  • 11.10.3 Mayo Clinic Rubella Diagnostic Testing Introduction
  • 11.10.4 Mayo Clinic Revenue in Rubella Diagnostic Testing Business (2017-2022)
  • 11.10.5 Mayo Clinic Recent Developments
• 11.11 Ortho Clinical Diagnostics
  • 11.11.1 Ortho Clinical Diagnostics Company Details
  • 11.11.2 Ortho Clinical Diagnostics Business Overview
  • 11.11.3 Ortho Clinical Diagnostics Rubella Diagnostic Testing Introduction
  • 11.11.4 Ortho Clinical Diagnostics Revenue in Rubella Diagnostic Testing Business (2017-2022)
  • 11.11.5 Ortho Clinical Diagnostics Recent Developments
• 11.12 True Health
  • 11.12.1 True Health Company Details
  • 11.12.2 True Health Business Overview
  • 11.12.3 True Health Rubella Diagnostic Testing Introduction
  • 11.12.4 True Health Revenue in Rubella Diagnostic Testing Business (2017-2022)
  • 11.12.5 True Health Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

• Table 1. Global Rubella Diagnostic Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of Flow Cytometry
• Table 3. Key Players of Latex Slide Agglutination Test
• Table 4. Key Players of Monoclonal Antibodies
• Table 5. Key Players of Immunoassays
• Table 6. Key Players of Serological Testing
• Table 7. Key Players of Clinical Evaluation
• Table 8. Global Rubella Diagnostic Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 9. Global Rubella Diagnostic Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 10. Global Rubella Diagnostic Testing Market Size by Region (2017-2022) & (US$ Million)
• Table 11. Global Rubella Diagnostic Testing Market Share by Region (2017-2022)
• Table 12. Global Rubella Diagnostic Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 13. Global Rubella Diagnostic Testing Market Share by Region (2023-2028)
• Table 14. Rubella Diagnostic Testing Market Trends
• Table 15. Rubella Diagnostic Testing Market Drivers
• Table 16. Rubella Diagnostic Testing Market Challenges
• Table 17. Rubella Diagnostic Testing Market Restraints
• Table 18. Global Rubella Diagnostic Testing Revenue by Players (2017-2022) & (US$ Million)
• Table 19. Global Rubella Diagnostic Testing Revenue Share by Players (2017-2022)
• Table 20. Global Top Rubella Diagnostic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rubella Diagnostic Testing as of 2021)
• Table 21. Ranking of Global Top Rubella Diagnostic Testing Companies by Revenue (US$ Million) in 2021
• Table 22. Global 5 Largest Players Market Share by Rubella Diagnostic Testing Revenue (CR5 and HHI) & (2017-2022)
• Table 23. Key Players Headquarters and Area Served
• Table 24. Key Players Rubella Diagnostic Testing Product Solution and Service
• Table 25. Date of Enter into Rubella Diagnostic Testing Market
• Table 26. Mergers & Acquisitions, Expansion Plans
• Table 27. Global Rubella Diagnostic Testing Market Size by Type (2017-2022) & (US$ Million)
• Table 28. Global Rubella Diagnostic Testing Revenue Market Share by Type (2017-2022)
• Table 29. Global Rubella Diagnostic Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 30. Global Rubella Diagnostic Testing Revenue Market Share by Type (2023-2028)
• Table 31. Global Rubella Diagnostic Testing Market Size by Application (2017-2022) & (US$ Million)
• Table 32. Global Rubella Diagnostic Testing Revenue Share by Application (2017-2022)
• Table 33. Global Rubella Diagnostic Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 34. Global Rubella Diagnostic Testing Revenue Share by Application (2023-2028)
• Table 35. North America Rubella Diagnostic Testing Market Size by Type (2017-2022) & (US$ Million)
• Table 36. North America Rubella Diagnostic Testing Market Size by Type (2023-2028) & (US$ Million)
• Table 37. North America Rubella Diagnostic Testing Market Size by Application (2017-2022) & (US$ Million)
• Table 38. North America Rubella Diagnostic Testing Market Size by Application (2023-2028) & (US$ Million)
• Table 39. North America Rubella Diagnostic Testing Market Size by Country (2017-2022) & (US$ Million)
• Table 40. North America Rubella Diagnostic Testing Market Size by Country (2023-2028) & (US$ Million)
• Table 41. Europe Rubella Diagnostic Testing Market Size by Type (2017-2022) & (US$ Million)
• Table 42. Europe Rubella Diagnostic Testing Market Size by Type (2023-2028) & (US$ Million)
• Table 43. Europe Rubella Diagnostic Testing Market Size by Application (2017-2022) & (US$ Million)
• Table 44. Europe Rubella Diagnostic Testing Market Size by Application (2023-2028) & (US$ Million)
• Table 45. Europe Rubella Diagnostic Testing Market Size by Country (2017-2022) & (US$ Million)
• Table 46. Europe Rubella Diagnostic Testing Market Size by Country (2023-2028) & (US$ Million)
• Table 47. Asia Pacific Rubella Diagnostic Testing Market Size by Type (2017-2022) & (US$ Million)
• Table 48. Asia Pacific Rubella Diagnostic Testing Market Size by Type (2023-2028) & (US$ Million)
• Table 49. Asia Pacific Rubella Diagnostic Testing Market Size by Application (2017-2022) & (US$ Million)
• Table 50. Asia Pacific Rubella Diagnostic Testing Market Size by Application (2023-2028) & (US$ Million)
• Table 51. Asia Pacific Rubella Diagnostic Testing Market Size by Region (2017-2022) & (US$ Million)
• Table 52. Asia Pacific Rubella Diagnostic Testing Market Size by Region (2023-2028) & (US$ Million)
• Table 53. Latin America Rubella Diagnostic Testing Market Size by Type (2017-2022) & (US$ Million)
• Table 54. Latin America Rubella Diagnostic Testing Market Size by Type (2023-2028) & (US$ Million)
• Table 55. Latin America Rubella Diagnostic Testing Market Size by Application (2017-2022) & (US$ Million)
• Table 56. Latin America Rubella Diagnostic Testing Market Size by Application (2023-2028) & (US$ Million)
• Table 57. Latin America Rubella Diagnostic Testing Market Size by Country (2017-2022) & (US$ Million)
• Table 58. Latin America Rubella Diagnostic Testing Market Size by Country (2023-2028) & (US$ Million)
• Table 59. Middle East and Africa Rubella Diagnostic Testing Market Size by Type (2017-2022) & (US$ Million)
• Table 60. Middle East and Africa Rubella Diagnostic Testing Market Size by Type (2023-2028) & (US$ Million)
• Table 61. Middle East and Africa Rubella Diagnostic Testing Market Size by Application (2017-2022) & (US$ Million)
• Table 62. Middle East and Africa Rubella Diagnostic Testing Market Size by Application (2023-2028) & (US$ Million)
• Table 63. Middle East and Africa Rubella Diagnostic Testing Market Size by Country (2017-2022) & (US$ Million)
• Table 64. Middle East and Africa Rubella Diagnostic Testing Market Size by Country (2023-2028) & (US$ Million)
• Table 65. Abbott Laboratories Company Details
• Table 66. Abbott Laboratories Business Overview
• Table 67. Abbott Laboratories Rubella Diagnostic Testing Product
• Table 68. Abbott Laboratories Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
• Table 69. Abbott Laboratories Recent Developments
• Table 70. Beckman Coulter Company Details
• Table 71. Beckman Coulter Business Overview
• Table 72. Beckman Coulter Rubella Diagnostic Testing Product
• Table 73. Beckman Coulter Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
• Table 74. Beckman Coulter Recent Developments
• Table 75. Bio Rad Laboratories Company Details
• Table 76. Bio Rad Laboratories Business Overview
• Table 77. Bio Rad Laboratories Rubella Diagnostic Testing Product
• Table 78. Bio Rad Laboratories Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
• Table 79. Bio Rad Laboratories Recent Developments
• Table 80. Biogate Laboratories Company Details
• Table 81. Biogate Laboratories Business Overview
• Table 82. Biogate Laboratories Rubella Diagnostic Testing Product
• Table 83. Biogate Laboratories Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
• Table 84. Biogate Laboratories Recent Developments
• Table 85. BioMerieux SA Company Details
• Table 86. BioMerieux SA Business Overview
• Table 87. BioMerieux SA Rubella Diagnostic Testing Product
• Table 88. BioMerieux SA Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
• Table 89. BioMerieux SA Recent Developments
• Table 90. Cigna Company Details
• Table 91. Cigna Business Overview
• Table 92. Cigna Rubella Diagnostic Testing Product
• Table 93. Cigna Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
• Table 94. Cigna Recent Developments
• Table 95. Diagnostic Laboratory of Oklahoma Company Details
• Table 96. Diagnostic Laboratory of Oklahoma Business Overview
• Table 97. Diagnostic Laboratory of Oklahoma Rubella Diagnostic Testing Product
• Table 98. Diagnostic Laboratory of Oklahoma Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
• Table 99. Diagnostic Laboratory of Oklahoma Recent Developments
• Table 100. GlaxoSmithKline Company Details
• Table 101. GlaxoSmithKline Business Overview
• Table 102. GlaxoSmithKline Rubella Diagnostic Testing Product
• Table 103. GlaxoSmithKline Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
• Table 104. GlaxoSmithKline Recent Developments
• Table 105. HealthLink BC Company Details
• Table 106. HealthLink BC Business Overview
• Table 107. HealthLink BC Rubella Diagnostic Testing Product
• Table 108. HealthLink BC Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
• Table 109. HealthLink BC Recent Developments
• Table 110. Mayo Clinic Company Details
• Table 111. Mayo Clinic Business Overview
• Table 112. Mayo Clinic Rubella Diagnostic Testing Product
• Table 113. Mayo Clinic Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
• Table 114. Mayo Clinic Recent Developments
• Table 115. Ortho Clinical Diagnostics Company Details
• Table 116. Ortho Clinical Diagnostics Business Overview
• Table 117. Ortho Clinical Diagnostics Rubella Diagnostic Testing Product
• Table 118. Ortho Clinical Diagnostics Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
• Table 119. Ortho Clinical Diagnostics Recent Developments
• Table 120. True Health Company Details
• Table 121. True Health Business Overview
• Table 122. True Health Rubella Diagnostic Testing Product
• Table 123. True Health Revenue in Rubella Diagnostic Testing Business (2017-2022) & (US$ Million)
• Table 124. True Health Recent Developments
• Table 125. Research Programs/Design for This Report
• Table 126. Key Data Information from Secondary Sources
• Table 127. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Rubella Diagnostic Testing Market Share by Type: 2021 VS 2028
• Figure 2. Flow Cytometry Features
• Figure 3. Latex Slide Agglutination Test Features
• Figure 4. Monoclonal Antibodies Features
• Figure 5. Immunoassays Features
• Figure 6. Serological Testing Features
• Figure 7. Clinical Evaluation Features
• Figure 8. Global Rubella Diagnostic Testing Market Share by Application: 2021 VS 2028
• Figure 9. Hospitals Case Studies
• Figure 10. Commercial Case Studies
• Figure 11. Physician Offices Case Studies
• Figure 12. Public Health Labs Case Studies
• Figure 13. Other Case Studies
• Figure 14. Rubella Diagnostic Testing Report Years Considered
• Figure 15. Global Rubella Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 16. Global Rubella Diagnostic Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 17. Global Rubella Diagnostic Testing Market Share by Region: 2021 VS 2028
• Figure 18. Global Rubella Diagnostic Testing Market Share by Players in 2021
• Figure 19. Global Top Rubella Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rubella Diagnostic Testing as of 2021)
• Figure 20. The Top 10 and 5 Players Market Share by Rubella Diagnostic Testing Revenue in 2021
• Figure 21. North America Rubella Diagnostic Testing Market Size YoY (2017-2028) & (US$ Million)
• Figure 22. North America Rubella Diagnostic Testing Market Size Market Share by Type (2017-2028)
• Figure 23. North America Rubella Diagnostic Testing Market Size Market Share by Application (2017-2028)
• Figure 24. North America Rubella Diagnostic Testing Market Size Share by Country (2017-2028)
• Figure 25. United States Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 26. Canada Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 27. Europe Rubella Diagnostic Testing Market Size YoY (2017-2028) & (US$ Million)
• Figure 28. Europe Rubella Diagnostic Testing Market Size Market Share by Type (2017-2028)
• Figure 29. Europe Rubella Diagnostic Testing Market Size Market Share by Application (2017-2028)
• Figure 30. Europe Rubella Diagnostic Testing Market Size Share by Country (2017-2028)
• Figure 31. Germany Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 32. France Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 33. U.K. Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 34. Italy Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 35. Russia Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 36. Nordic Countries Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 37. Asia-Pacific Rubella Diagnostic Testing Market Size YoY (2017-2028) & (US$ Million)
• Figure 38. Asia Pacific Rubella Diagnostic Testing Market Size Market Share by Type (2017-2028)
• Figure 39. Asia Pacific Rubella Diagnostic Testing Market Size Market Share by Application (2017-2028)
• Figure 40. Asia Pacific Rubella Diagnostic Testing Market Size Share by Region (2017-2028)
• Figure 41. China Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 42. Japan Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 43. South Korea Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 44. Southeast Asia Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 45. India Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 46. Australia Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

• Figure 47. Latin America Rubella Diagnostic Testing Market Size YoY (2017-2028) & (US$ Million)
• Figure 48. Latin America Rubella Diagnostic Testing Market Size Market Share by Type (2017-2028)
• Figure 49. Latin America Rubella Diagnostic Testing Market Size Market Share by Application (2017-2028)
• Figure 50. Latin America Rubella Diagnostic Testing Market Size Share by Country (2017-2028)
• Figure 51. Mexico Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 52. Brazil Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 53. Middle East & Africa Rubella Diagnostic Testing Market Size YoY (2017-2028) & (US$ Million)
• Figure 54. Middle East and Africa Rubella Diagnostic Testing Market Size Market Share by Type (2017-2028)
• Figure 55. Middle East and Africa Rubella Diagnostic Testing Market Size Market Share by Application (2017-2028)
• Figure 56. Middle East and Africa Rubella Diagnostic Testing Market Size Share by Country (2017-2028)
• Figure 57. Turkey Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 58. Saudi Arabia Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 59. UAE Rubella Diagnostic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 60. Abbott Laboratories Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
• Figure 61. Beckman Coulter Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
• Figure 62. Bio Rad Laboratories Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
• Figure 63. Biogate Laboratories Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
• Figure 64. BioMerieux SA Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
• Figure 65. Cigna Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
• Figure 66. Diagnostic Laboratory of Oklahoma Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
• Figure 67. GlaxoSmithKline Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
• Figure 68. HealthLink BC Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
• Figure 69. Mayo Clinic Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
• Figure 70. Ortho Clinical Diagnostics Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
• Figure 71. True Health Revenue Growth Rate in Rubella Diagnostic Testing Business (2017-2022)
• Figure 72. Bottom-up and Top-down Approaches for This Report
• Figure 73. Data Triangulation
• Figure 74. Key Executives Interviewed